Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies

Схожие документы

• Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
  по: Mizoguchi, Takanori, et al.
  Опубликовано: (2017)
• Effect of Topical Cyclosporine 0.05% in Allergic Conjunctivitis
  по: Sonali Bhalla, et al.
  Опубликовано: (2015-01-01)
• Clinical Experience of Using 0.2 % Olopatadin in the Allergic Conjunctivitis Treatment
  по: S. V. Yanchenko, et al.
  Опубликовано: (2019-10-01)
• Clinical Experience of Using 0.2 % Olopatadin in the Allergic Conjunctivitis Treatment
  по: S. V. Yanchenko, et al.
  Опубликовано: (2019-10-01)
• Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle‐controlled study
  по: Liu, Rui‐fen, et al.
  Опубликовано: (2016)